AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From CBS Marketwatch (Stories))
BOSTON (CBS.MW) -- Shares of Cyberonics tumbled more than 10 percent on Friday amid concerns that approval of the company's depression therapy device could be delayed.
Houston-based Cyberonics saw its shares plunge $3.22 to $26.59. Shares had been off by as much as 20 percent in pre-market trading.
The medical device maker said late Thursday that a crucial Food and Drug Administration advisory panel review of the company's device to combat depression will not take place until July, as opposed to an earlier expectation of April.
Cyberonics also disclosed that regulators view the marketing application for the…